Impact of mental health comorbidity in children and young adults with inflammatory bowel disease: a UK population-based cohort studyRachel Cooney, Kevin Barrett, Richard K Russell
28 February 2024
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancerPierre Nahon, Maxime Ronot, Olivier Sutter, Pierre-André Natella, Samia Baloul, Isabelle Durand-Zaleski, Etienne Audureau
17 February 2024
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trialNikolaj Torp, Mads Israelsen, Minneke Coenraad, Maria Papp, Debbie Shawcross, Marko Korenjak, Paolo Angeli, Wim Laleman, Adria Juanola, Pere Gines, Jonel Trebicka, Aleksander Krag, , MICROB-PREDICT Consortium, Vicente ArroyoSee the full list of authors
14 February 2024
Interventional embolisation for patients with cirrhosis and recurrent or persistent hepatic encephalopathy related to spontaneous portosystemic shunts: protocol for a prospective, non-randomised controlled studyQiao Ke, Ting Lin, Xiaojuan Lei, Xiadi Weng, Jian He, Xinhui Huang, Ling Li, Wu-Hua Guo
12 February 2024
‘That gave me a lot of comfort, that he would ask my opinion about how we wanted to talk about this’: A qualitative analysis of clinical communication experiences of ostomy patientsBraidyn S Lazenby, Ashley Guidry, Erin E Donovan, René Dailey, Srinivas Joga Ivatury
7 February 2024
Protocol for the Gut Bugs in Autism Trial: a double-blind randomised placebo-controlled trial of faecal microbiome transfer for the treatment of gastrointestinal symptoms in autistic adolescents and adultsRy Y Tweedie-Cullen, Karen Leong, Brooke C Wilson, José G B Derraik, Benjamin B Albert, Ruth Monk, Tommi Vatanen, Christine Creagh, Marysia Depczynski, Taygen Edwards, Kathryn Beck, Hiran Thabrew, Justin M O'Sullivan, Wayne S Cutfield
6 February 2024
Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocolRoberta Loveikyte, Marjolijn Duijvestein, Zlatan Mujagic, Rogier L Goetgebuer, Gerard Dijkstra, Andrea E van der Meulen-de Jong
30 January 2024
‘Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation’: study protocol of a non-randomised clinical trialAllard G Wijma, Bart C Bongers, Coby Annema, Rienk Dekker, Hans Blokzijl, Job AM van der Palen, Vincent E De Meijer, Frans JC Cuperus, Joost M Klaase
29 January 2024
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis: a protocol of systematic review and meta-analysis of placebo-controlled, randomised clinical trialsXuan Qin, Menghui Wang, Wei Zhang, Wenji Liu, Hongxin Shu, Xiaowei Xiong
24 January 2024
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation studyHamish Miller, David Harman, Guruprasad Padur Aithal, Pinelopi Manousou, Jeremy F Cobbold, Richard Parker, David Sheridan, Philip N Newsome, Fredrik Karpe, Matthew Neville, Wiebke Arlt, Alice J Sitch, Marta Korbonits, Michael Biehl, William AlazawiSee the full list of authors
18 January 2024